LYTIR

Company · MRNA

Moderna, Inc.

Nasdaq's symbol directory lists MRNA on Nasdaq as “Moderna, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 13 occasions ($72.4M); 9 planned-sale notices; 4 filings by holders of 5% or more; 3 congressional trade disclosures; 5 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 27, No. 26, No. 17

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $72.4M in total.May: Insider sales $3.3MJun: Insider sales $2.9MJul: Insider sales $3.6MAug: Insider sales $28.7MSep: Insider sales $16.9MOct: Insider sales $17.0MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $72.4M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Hoge Stephen, President sold on 7 days all under a 10b5-1 plan latest Oct 15, 2026 sold $37.6M
  2. Bancel Stephane, Chief Executive Officer sold on 1 day all under a 10b5-1 plan latest Aug 5, 2026 sold $28.7M
  3. Mock James M, Chief Financial Officer sold on 1 day all under a 10b5-1 plan latest Sep 10, 2026 sold $4.7M
  4. Klinger Shannon Thyme, Chief Legal Officer sold on 2 days all under a 10b5-1 plan latest Sep 1, 2026 sold $659K
  5. AFEYAN NOUBAR sold on 1 day latest May 21, 2026 sold $434K
  6. Hussain Abbas sold on 1 day all under a 10b5-1 plan latest May 1, 2026 sold $265K
Every trade (13)
  1. SELLHoge Stephen, President sold Oct 15, 2026 39,145 shares 10b5-1 plan (scheduled) filing $8.6M
  2. SELLHoge Stephen, President sold Oct 14, 2026 39,224 shares 2 legs combined 10b5-1 plan (scheduled) filing $8.4M
  3. SELLHoge Stephen, President sold Sep 15, 2026 40,281 shares 10b5-1 plan (scheduled) filing $5.9M
  4. SELLHoge Stephen, President sold Sep 14, 2026 40,294 shares 10b5-1 plan (scheduled) filing $5.8M
  5. SELLMock James M, Chief Financial Officer sold Sep 10, 2026 34,836 shares 2 legs combined 10b5-1 plan (scheduled) filing $4.7M
  6. SELLKlinger Shannon Thyme, Chief Legal Officer sold Sep 1, 2026 3,471 shares 10b5-1 plan (scheduled) filing $486K
  7. SELLBancel Stephane, Chief Executive Officer sold Aug 5, 2026 499,246 shares 4 legs combined 10b5-1 plan (scheduled) filing $28.7M
  8. SELLHoge Stephen, President sold Jul 15, 2026 53,336 shares 10b5-1 plan (scheduled) filing $3.6M
  9. SELLHoge Stephen, President sold Jun 15, 2026 53,336 shares 10b5-1 plan (scheduled) filing $2.7M
  10. SELLKlinger Shannon Thyme, Chief Legal Officer sold Jun 4, 2026 3,471 shares 10b5-1 plan (scheduled) filing $174K
  11. SELLAFEYAN NOUBAR sold May 21, 2026 9,263 shares filing $434K
  12. SELLHoge Stephen, President sold May 15, 2026 53,336 shares 10b5-1 plan (scheduled) filing $2.6M
  13. SELLHussain Abbas sold May 1, 2026 5,682 shares 10b5-1 plan (scheduled) filing $265K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Hoge Stephen filed Oct 15, 2026 Officer 39,145 shares planned sale date 10/15/2026 filing $8.6M
  2. Hoge Stephen filed Oct 14, 2026 Officer 39,224 shares planned sale date 10/14/2026 filing $8.4M
  3. Hoge Stephen filed Sep 15, 2026 Officer 40,281 shares planned sale date 09/15/2026 filing $5.9M
  4. Hoge Stephen filed Sep 14, 2026 Officer 40,294 shares planned sale date 09/14/2026 filing $5.8M
  5. Mock James M filed Sep 10, 2026 Officer 34,836 shares planned sale date 09/10/2026 filing $4.7M
  6. Klinger Shannon Thyme filed Sep 1, 2026 Officer 3,471 shares planned sale date 09/01/2026 filing $486K
  7. Bancel Stephane filed Aug 5, 2026 Officer 499,246 shares planned sale date 08/05/2026 filing $29.0M
  8. Hoge Stephen filed Jul 15, 2026 Officer 53,336 shares planned sale date 07/15/2026 filing $3.6M
  9. SAGAN PAUL filed Jun 18, 2026 Former Director 25,770 shares planned sale date 06/18/2026 filing $1.7M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 58,929,948 shares filing 14.8%
  2. Capital World Investors filed Aug 12, 2026 Schedule 13G passive filing 5.6%
  3. FMR LLC filed Aug 6, 2026 Schedule 13G/A passive 51,803,891 shares filing 13.1%
  4. BAILLIE GIFFORD & CO filed Jul 24, 2026 Schedule 13G/A passive 18,206,778 shares filing 4.6%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Maria Elvira Salazar (R-FL27): Sale Sep 24, 2026 reported Oct 7, 2026 one of 42 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Maria Elvira Salazar (R-FL27): Purchase Aug 19, 2026 reported Sep 9, 2026 one of 12 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  3. Maria Elvira Salazar (R-FL27): Sale Aug 19, 2026 reported Sep 9, 2026 one of 12 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 6, 2026
  2. Departure or appointment of directors or officers; Regulation FD disclosure filing Sep 30, 2026
  3. Entry into a material definitive agreement; Creation of a direct financial obligation; Unregistered sales of equity securities; Other events filing Sep 1, 2026
  4. Results of operations and financial condition filing Jul 31, 2026
  5. Departure or appointment of directors or officers; Regulation FD disclosure filing Jul 8, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.